ArticlePloS one2021

Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.

Kimberly Saddler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.